Imerys S.A. (LON:0NPX)
London · Delayed Price · Currency is GBP · Price in EUR 21.96
+0.16 (0.73%)
At close: Oct 23, 2025
Imerys Revenue
Imerys had revenue of 885.60M EUR in the quarter ending June 30, 2025, a decrease of -10.78%. This brings the company's revenue in the last twelve months to 3.44B, down -7.71% year-over-year. In the year 2024, Imerys had annual revenue of 3.60B, down -4.99%.
Revenue (ttm)
3.44B EUR
Revenue Growth
-7.71%
P/S Ratio
0.55
Revenue / Employee
228.61K EUR
Employees
15,060
Market Cap
1.62B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.60B | -189.50M | -4.99% |
| Dec 31, 2023 | 3.79B | -487.20M | -11.38% |
| Dec 31, 2022 | 4.28B | 616.90M | 16.83% |
| Dec 31, 2021 | 3.66B | -133.80M | -3.52% |
| Dec 31, 2020 | 3.80B | -556.00M | -12.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |